Download PDF
Thromb Haemost 1995; 73(01): 106-111
DOI: 10.1055/s-0038-1653733
Original Article
Coagulation
Schattauer GmbH Stuttgart

Polymorphisms of the Beta Fibrinogen Gene and Plasma Fibrinogen Concentration in Caucasian and Japanese Population Samples

Hiroyasu Iso
1   The Institute of Community Medicine, University of Tsukuba, Tsukuba-shi, Japan
,
Aaron R Folsom
2   The Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN, USA
,
John C Winkelmann
3   The Department of Medicine and Institute of Human Genetics, Medical School, University of Minnesota, Minneapolis, MN, USA
,
Kazuko Koike
1   The Institute of Community Medicine, University of Tsukuba, Tsukuba-shi, Japan
,
Shoji Harada
1   The Institute of Community Medicine, University of Tsukuba, Tsukuba-shi, Japan
,
Beryl Greenberg
4   The Clinical Research Center Core Laboratory, Medical School, University of Minnesota, Minneapolis, MN, USA
,
Shinichi Sato
5   The Department of Epidemiology and Mass Examination, The Center for Adult Diseases, Osaka, Japan
,
Takashi Shimamoto
1   The Institute of Community Medicine, University of Tsukuba, Tsukuba-shi, Japan
,
Minoru lida
5   The Department of Epidemiology and Mass Examination, The Center for Adult Diseases, Osaka, Japan
,
Yoshio Komachi
6   The Osaka Prefectural Institute of Public Health, Osaka, Japan
› Author Affiliations
Further Information

Publication History

Received 19 July 1994

Accepted after revision 27 September 1994

Publication Date:
09 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

We reported previously that plasma fibrinogen was significantly higher in U.S. Caucasians than in Japanese, which may contribute to the higher mortality rate of coronary heart disease in the United States than in Japan. To examine the contribution of genetic variations to the race difference in plasma fibrinogen levels, restriction fragment length polymorphisms (RFLPs) of the beta fibrinogen gene were examined in 293 nonsmoking Caucasians and Japanese men and women aged 47-69 years. Three RFLPs were detected by digestion of genomic DNA using the BclI restriction enzyme, polymerase chain reaction (PCR) products using HaeIII and HindIII. The alleles B2 (4.2 kb, BclI digestion), H2 (957 b, HaeIII) and Hd2 (465 b, HindIII) were associated with higher fibrinogen concentrations in previous studies. Because of a strong linkage disequilibrium between HaeIII and HindIII polymorphisms, the data of HindIII was presented. The frequency of the B2 allele was 22% (95% Cl: 17-27%) for Caucasians and 13% (10-17%) for Japanese (the difference: p <0.01). The respective frequency of the Hd2 allele was 26% (21-31%) and 12% (8-16%) (p <0.001). After controlling for age, body mass index, alcohol intake, triglycerides, fish intake, and for women, menopausal status and hormone replacement therapy, the adjusted mean fibrinogen level among Caucasians was 289 mg/dl for genotype B1B1 and 301 mg/dl for genotype B1B2 or B2B2 combined (p = 0.18), and 285 mg/dl for Hd1Hd1 and 306 mg/dl for Hd1Hd2 or Hd2Hd2 combined (p = 0.03). The respective mean values among Japanese were 251 mg/dl for B1B1 and 257 mg/dl for B1B2 or B2B2 combined (p = 0.37), 248 mg/dl for Hd1Hd1 and 259 mg/dl for Hd1Hd2 or Hd2Hd2 combined (p = 0.16). These polymorphisms had a similar effect on plasma fibrinogen concentrations for both men and women. The results suggest that a genetic difference may partly explain the higher plasma fibrinogen in Caucasians than in Japanese.

 

  • References

  • 1 Meade TW, North WR S, Chakrabarti R, Stirling Y, Haines AP, Thompson SG. Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1980; 1: 1050-1054
    PubMedGoogle Scholar
  • 2 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR S, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537
    PubMedGoogle Scholar
  • 3 Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505
    CrossrefPubMedGoogle Scholar
  • 4 Stone MC, Thorp JM. Plasma fibrinogen – a major coronary risk factor. J R Coll Gen Pract 1985; 35: 565-569
    PubMedGoogle Scholar
  • 5 Kannel WB, Wolf PA, Castelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study JAMA 1987; 258: 1183-1186
    CrossrefPubMedGoogle Scholar
  • 6 Yarnell JW G, Baker IA, Sweetnam PM, Bainton D, O’Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies Circulation 1991; 83: 836-844
    CrossrefPubMedGoogle Scholar
  • 7 Meade TW, Chakrabarti R, Haines AP, North WR S, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979; 1: 153-156
    CrossrefPubMedGoogle Scholar
  • 8 Meade TW, Haines AP, Imeson JD, Stirling Y, Thompson SG. Menopausal status and haemostatic variables. Lancet 1983; 1: 22-24
    PubMedGoogle Scholar
  • 9 Balleisen L, Bailey J, Epping PH, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using and menopause. Thromb Haemost 1985; 54: 475-479
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987; 2: 986-988
    PubMedGoogle Scholar
  • 11 Hostmark AT, Bjerkedal T, Kierulf P, Flaten H, Ulshagen K. Fish oil and plasma fibrinogen. Br Med J 1988; 297: 180-181
    CrossrefPubMedGoogle Scholar
  • 12 Iso H, Folsom AR, Wu KK, Finch A, Munger RG, Sato S, Shimamoto T, Terao T, Komachi Y. Hemostatic variables in Japanese and Caucasian men. Plasma fibrinogen, factor VIIc, factor VIIIc, and von Willebrand factor and their relations to cardiovascular disease risk factors Am J Epidemiol 1989; 130: 925-934
    CrossrefPubMedGoogle Scholar
  • 13 Iso H, Folsom AR, Sato S, Wu KK, Shimamoto T, Iida M, Komachi Y. Plasma fibrinogen and its correlates in US and Japanese population samples. Arterios Thromb 1993; 13: 783-790
    PubMedGoogle Scholar
  • 14 Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205
    CrossrefPubMedGoogle Scholar
  • 15 Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg Survey1989-1990 Arterios Thromb 1992; 12: 780-788
    PubMedGoogle Scholar
  • 16 Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987; 1: 1452-1455
    PubMedGoogle Scholar
  • 17 Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promoter region of the β fibrinogen gene is associated with plasma fibrinogen levels in smokers and in non-smokers. Thromb Haemost 1991; 65: 487-490
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Thomas A, Green F, Cruickshank K, Humphries S. The HaeIII and HindIII polymorphisms of the beta fibrinogen gene; racial differences in frequency and association (abstract). Thromb Haemost 1991; 65: 897
    PubMedGoogle Scholar
  • 19 Scarabin PY, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction, The ECTIM Study. Arterios Thromb 1993; 13: 886-891
    PubMedGoogle Scholar
  • 20 Yu S, Sher B, Kudryk B, Redman CM. Intracellular assembly of human fibrinogen. J Biol Chem 1983; 258: 13407-13410
    PubMedGoogle Scholar
  • 21 Berg K, Kierulf P. DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration. Clin Genetics 1989; 36: 229-235
    PubMedGoogle Scholar
  • 22 Conner JM, Fowkes FG R, Wood J, Smith FB, Donnan PT, Lowe GD O. Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet 1992; 29: 480-482
    PubMedGoogle Scholar
  • 23 Hamsten A, Iselius L, De Faire U, Blombäck M. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 1987; 2: 988-991
    PubMedGoogle Scholar
  • 24 The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989; 129: 687-702
    CrossrefPubMedGoogle Scholar
  • 25 Shimamoto T, Kochami Y, Inada H, Doi M, Iso H, Sato S, Kitamura A, Iida M, Konishi M, Nakanishi N, Terao A, Naito Y, Kojima S. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989; 79: 503-515
    CrossrefPubMedGoogle Scholar
  • 26 National Heart, Lung and Blood Institute. ARIC Manuals of Operations: 7.Blood Collection and Processing;. 8. Lipid and Lipoprotein Determination;. 9. Hemostasis Determinations Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina;
    Google Scholar
  • 27 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246
    CrossrefPubMedGoogle Scholar
  • 28 Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Biochem 1984; 22: 165-174
    PubMedGoogle Scholar
  • 29 Manual of Laboratory Operations, Lipid Research Clinics Program: Lipid and Lipoprotein Analysis. Bethesda, MD, US: Department of Health and Welfare Publication; 1974. vol 1 75-628
  • 30 Nakamura M, Morita M, Yabuuchi E, Yukami M, Kuruma S, Kuritani C, Kanatsu Y, Nishiwaki E, Ueshima H, Iida M, Komachi Y. The evaluation and the results of cooperative cholesterol and triglyceride standardization program by WHO-CDC. Rinsho Byori 1982; 30: 325-332 (in Japanese)
    PubMedGoogle Scholar
  • 31 Chung DW, Benits GQ, Rixon MW, Mace Jr M, Davie EW. Characterization of complementary deoxyribonucleic acid and genomic deoxyribonucleic acid for the β chain of human fibrinogen. Biochemistry 1983; 22: 3244-3250
    CrossrefPubMedGoogle Scholar
  • 32 Chakrabarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HH. Nonuniform recombination within the human beta-globulin gene cluster. Am J Hum Genet 1984; 36: 1239-1258
    PubMedGoogle Scholar
  • 33 Owan I, Suda T. Strategy of osteoporosis therapy. J Clin Exp Med (IGAKU NO AYUMI) 1992; 160: 115-117 (in Japanese)
    PubMedGoogle Scholar
  • 34 Iso H, Sato S, Folsom AR, Shimamoto T, Terao A, Munger RG, Kitamura A, Konishi M, Iida M, Komachi Y. Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American Men. Int J Epidemiol 1989; 18: 374-381
    CrossrefPubMedGoogle Scholar
  • 35 Thompson SG, Martin JC, Meade TW. Sources of variability in coagulation factor assays. Thromb Haemost 1987; 58: 1073-1077
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Huber P, Dalmon J, Courtois G, Laurent M, Assouline Z, Marguerie G. Characterization of the 5’-flankling region for the human fibrinogen β gene. Nucl Acids Res 1987; 15: 1615-1625
    CrossrefPubMedGoogle Scholar